35676256|t|Targeting parvalbumin promotes M2 macrophage polarization and energy expenditure in mice.
35676256|a|Exercise benefits M2 macrophage polarization, energy homeostasis and protects against obesity partially through exercise-induced circulating factors. Here, by unbiased quantitative proteomics on serum samples from sedentary and exercised mice, we identify parvalbumin as a circulating factor suppressed by exercise. Parvalbumin functions as a non-competitive CSF1R antagonist to inhibit M2 macrophage activation and energy expenditure in adipose tissue. More importantly, serum concentrations of parvalbumin positively correlate with obesity in mouse and human, while treating mice with a recombinant parvalbumin blocker prevents its interaction with CSF1R and promotes M2 macrophage polarization and ameliorates diet-induced obesity. Thus, although further studies are required to assess the significance of parvalbumin in mediating the effects of exercise, our results implicate parvalbumin as a potential therapeutic strategy against obesity in mice.
35676256	10	21	parvalbumin	Gene	19293
35676256	84	88	mice	Species	10090
35676256	176	183	obesity	Disease	MESH:D009765
35676256	328	332	mice	Species	10090
35676256	346	357	parvalbumin	Gene	19293
35676256	406	417	Parvalbumin	Gene	19293
35676256	449	454	CSF1R	Gene	1436
35676256	586	597	parvalbumin	Gene	19293
35676256	624	631	obesity	Disease	MESH:D009765
35676256	635	640	mouse	Species	10090
35676256	645	650	human	Species	9606
35676256	667	671	mice	Species	10090
35676256	691	702	parvalbumin	Gene	19293
35676256	741	746	CSF1R	Gene	12978
35676256	816	823	obesity	Disease	MESH:D009765
35676256	899	910	parvalbumin	Gene	19293
35676256	971	982	parvalbumin	Gene	19293
35676256	1027	1034	obesity	Disease	MESH:D009765
35676256	1038	1042	mice	Species	10090
35676256	Association	12978	19293
35676256	Association	MESH:D009765	19293
35676256	Negative_Correlation	1436	19293

